INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 3.960
-0.020 (-0.50%)
At close: May 13, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 425.6 million as of May 15, 2026. Its market cap has decreased by -13.00% in one year.
Market Cap
425.60M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.96
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has decreased from 452.37M to 425.60M, a decrease of -5.92%. That is a compound annual growth rate of -1.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 425.60M | 11.45% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.32B |
| Circio Holding ASA | 2.79B |
| Nordhealth AS | 1.99B |
| Photocure ASA | 1.68B |
| Lytix Biopharma ASA | 815.14M |
| Omda AS | 789.55M |
| Gentian Diagnostics ASA | 602.89M |
| Zelluna ASA | 556.92M |